Therefore, our study demonstrates that Zic2/Runx2/NOLC1 signaling axis promotes ccRCC progression, providing a set of potential targets and prognostic indicators for patients with ccRCC. The gene discussed is RUNX2; the disease is nonpapillary renal cell carcinoma.